Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.76% | 10.38% | 7.11% | -25.18% | -26.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.76% | 10.38% | 7.11% | -25.18% | -26.49% |
| Cost of Revenue | 1.37% | -5.40% | -7.82% | 0.12% | -2.07% |
| Gross Profit | -4.47% | 10.95% | 14.31% | -13.12% | -12.14% |
| SG&A Expenses | 1.63% | 8.48% | 6.89% | -7.00% | -8.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.66% | 17.64% | 14.57% | -4.92% | -1.12% |
| Operating Income | -18.95% | -17.72% | -14.66% | 4.65% | 0.74% |
| Income Before Tax | -10.04% | -18.37% | -14.24% | -3.40% | -56.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.04% | -18.37% | -14.24% | -3.40% | -56.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.04% | -18.37% | -14.24% | -3.40% | -56.96% |
| EBIT | -18.95% | -17.72% | -14.66% | 4.65% | 0.74% |
| EBITDA | -18.88% | -17.31% | -14.12% | 5.15% | 1.20% |
| EPS Basic | 44.71% | 24.53% | 16.42% | 3.86% | -57.13% |
| Normalized Basic EPS | 39.40% | 15.41% | 7.80% | 8.41% | 6.89% |
| EPS Diluted | 44.71% | 24.53% | 16.42% | 4.04% | -55.30% |
| Normalized Diluted EPS | 39.40% | 15.41% | 7.80% | 8.41% | 4.44% |
| Average Basic Shares Outstanding | 176.80% | 80.57% | 23.78% | 12.57% | 21.98% |
| Average Diluted Shares Outstanding | 176.80% | 80.57% | 23.78% | 12.57% | 20.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | 0.86% | 0.35% | -0.28% | -- |